Vedolizumab and Extraintestinal Manifestations in Inflammatory Bowel Disease (vol 81, pg 333, 2021)

被引：0
|
作者：
Hanzel, Jurij [1 ,2 ,7 ]
Ma, Christopher [2 ,3 ]
Vande Casteele, Niels [2 ,4 ]
Khanna, Reena [5 ]
Jairath, Vipul [2 ,5 ,6 ]
Feagan, Brian G. [2 ,5 ,6 ,8 ]
机构：
[1] Univ Med Ctr Ljubljana, Dept Gastroenterol, Ljubljana, Slovenia
[2] Alimentiv, #200,100 Dundas St, London N6A 5B6, ON, Canada
[3] Univ Calgary, Cumming Sch Med, Div Gastroenterol & Hepatol, 6D61 Teaching Res Wellness Bldg,3280 Hosp Dr NW, Calgary, AB T2N 4Z6, Canada
[4] Univ Calif San Diego, Dept Med, 9500 Gilman Dr #0956, La Jolla, CA 92093 USA
[5] Univ Western Ontario, Div Gastroenterol, 1151 Richmond St, London N6A 2K7, ON, Canada
[6] Univ Western Ontario, Dept Epidemiol & Biostat, London, ON, Canada
[7] Hullenbergweg 278-308, NL-1101BV Amsterdam, Netherlands
[8] Univ Western Ontario, Dept Med, London, ON, Canada
来源：
DRUGS | 2021年 / 81卷 / 14期
关键词：
D O I：
10.1007/s40265-021-01596-w
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1697 / 1697
页数：1
相关论文
共 50 条
  • [1] Vedolizumab and Extraintestinal Manifestations in Inflammatory Bowel Disease
    Hanzel, Jurij
    Ma, Christopher
    Vande Casteele, Niels
    Khanna, Reena
    Jairath, Vipul
    Feagan, Brian G.
    DRUGS, 2021, 81 (03) : 333 - 347
  • [2] Vedolizumab and Extraintestinal Manifestations in Inflammatory Bowel Disease
    Jurij Hanzel
    Christopher Ma
    Niels Vande Casteele
    Reena Khanna
    Vipul Jairath
    Brian G. Feagan
    Drugs, 2021, 81 : 333 - 347
  • [3] Correction to: Vedolizumab and Extraintestinal Manifestations in Inflammatory Bowel Disease
    Jurij Hanzel
    Christopher Ma
    Niels Vande Casteele
    Reena Khanna
    Vipul Jairath
    Brian G. Feagan
    Drugs, 2021, 81 : 1697 - 1697
  • [4] EFFECTS OF VEDOLIZUMAB ON EXTRAINTESTINAL MANIFESTATIONS IN INFLAMMATORY BOWEL DISEASE
    Dimopoulos, Christina
    Hung, Kenneth
    Proctor, Deborah
    Ruggiero, Eilzabeth
    Al-Bawardy, Badr
    GASTROENTEROLOGY, 2020, 158 (03) : S32 - S33
  • [5] EFFECTS OF VEDOLIZUMAB ON EXTRAINTESTINAL MANIFESTATIONS IN INFLAMMATORY BOWEL DISEASE
    Dimopoulos, Christina
    Hung, Kenneth
    Proctor, Deborah
    Ruggiero, Eilzabeth
    Al-Bawardy, Badr
    INFLAMMATORY BOWEL DISEASES, 2020, 26 : S19 - S20
  • [6] Ustekinumab and vedolizumab for extraintestinal manifestations in inflammatory bowel disease
    Livne-Margolin, M.
    Ling, D.
    Konyo, S. Attia
    Haj, O.
    Abitbol, C. M.
    Ben-Horin, S.
    Kopylov, U.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I429 - I430
  • [7] EFFECTS OF VEDOLIZUMAB ON EXTRAINTESTINAL MANIFESTATIONS IN INFLAMMATORY BOWEL DISEASE
    Dimopoulos, Christina
    Hung, Kenneth W.
    Proctor, Deborah D.
    Ruggiero, Elizabeth
    Al-Bawardy, Badr
    GASTROENTEROLOGY, 2020, 158 (06) : S675 - S675
  • [8] Ustekinumab and vedolizumab for extraintestinal manifestations in inflammatory bowel disease
    Livne-Margolin, M.
    Ling, D.
    Konyo, S. Attia
    Haj, O.
    Abitbol, C. M.
    Ben-Horin, S.
    Kopylov, U.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I429 - I430
  • [9] Effects of Vedolizumab Therapy on Extraintestinal Manifestations in Inflammatory Bowel Disease
    Fleisher, Mark
    Marsal, Jan
    Lee, Scott D.
    Frado, Laura E.
    Parian, Alyssa
    Korelitz, Burton I.
    Feagan, Brian G.
    DIGESTIVE DISEASES AND SCIENCES, 2018, 63 (04) : 825 - 833
  • [10] Effects of Vedolizumab Therapy on Extraintestinal Manifestations in Inflammatory Bowel Disease
    Mark Fleisher
    Jan Marsal
    Scott D. Lee
    Laura E. Frado
    Alyssa Parian
    Burton I. Korelitz
    Brian G. Feagan
    Digestive Diseases and Sciences, 2018, 63 : 825 - 833
12345